breast cancer Flashcards

(25 cards)

1
Q

commonest type of breast cancer

A

invasive ductal carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

indications for mastectomy

A
  • multifocal tumour
  • central tumour
  • large lesion in small breast
  • DCIS >4cm

(patient choice)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

indications for wide local excision

A
  • solitary lesion
  • peripheral tumour
  • small lesion in big breast
  • DCIS <4cm

(patient choice)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

prognostic scoring system used for breast cancer

A

Nottingham Prognostic Index
- gives indication of 5 year suvival

  • includes tumour size x 0.2 + lymph node score + grade score
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

breast cancer risk factors

A

nulliparity, 1st child >30
early menarche, late menopause

COCP
not breastfeeding
p53 gene mutations
obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

age and frequency of breast screening

A

50-70yrs
- offered every 3 years

after age of 70, encouraged to make their own appointments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

inflammatory breast cancer pathophys

A

cancerous cells block lymph drainage in an inflamed appearance of the breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 week wait referal criteria

A

age >=30
- unexplained breast lump with or without pain

age >=50 with any of these sx in ONE nipple only;
- discharge
- retraction
- other changes of concern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

when to consider 2 week wait referral

A
  • skin changes that suggest breast cancer
  • age >=30 with unexplained lump in axilla
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

management of <30s with unexplained breast lump with or without pain

A

non-urgent referral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

who gets surgery for breast cancer

A

everyone except frail old ladies with metastatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

prior to surgery, what determines management of breast cancer

A

the presence / absence of axillary lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

management of women with NO palpable axillary lymph pre-surgery

A

pre-operative axillary ultrasound before surgery

  • if negative –> sentinal node biopsy to assess nodal burden
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

management of women WITH palpable axillary lymph pre-surgery

A

axillary node clearance in primary surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

complications fo axillay node clearance

A

lymphoedema

functional arm impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

in those who have had a wide local excision, how can they reduce the risk of recurrence

A

breast radiotherapy after !

  • reduces recurrence by 2/3rds
17
Q

hormonal management of (ER+) breast cancer in pre- and peri-menopausal women

18
Q

hormonal management of ER+ breast cancer in postmenopausal women

A

aromatase inhibitors
-> anastrozole

(ER+)

19
Q

side effects of tamoxifen

A

increased risk of ;
- endometrial cancer
- VTE
- menopausal sx - hot flushes

menstrual disturbance - vag bleeding, amenorrhoea

20
Q

biologic therapy used for HER2 + breast cancer

A

trastuzumab (Herceptin)

!! cant be used if history of heart disorders

21
Q

role of chemotherapy in breast cancer management

A

prior to surg - downstage tumour

after surg - if axillary node disease
–> FEC-D used in this situ

22
Q

tamoxifen !

A

selective oestrogen receptor modulator (SERM)

used in mx of oestrogen receptor positive BC (ER+)

23
Q

aromatase inhibitor side effects

A

osteoporosis
hot flushes
arthralgia, myalgia
insomnia

24
Q

what test must be done before initiaing anastrozole

A

DEXA scan !!

can cause osteoporosis

25
aromatase inhibitors MoA
reduce peripheral oestrogen synthesis - aromatisation accounts for majority of oestrogen in post menopausal women (anastrozole + letrozole)